Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Synthesis, self-aggregation and cryopreservation effects of perylene bisimide–glycopeptide conjugates
Xu
He
ab,
Bing
Hu
ab,
Yan
Yang
bc,
Hong-Yu
Zhu
ab,
Rui-Xue
Rong
bc,
Xiao-Liu
Li
*ab and
Ke-Rang
Wang
*ab
aCollege of Chemistry and Environmental Science, Hebei University, Baoding, P. R. China. E-mail: kerangwang@hbu.edu.cn; lixl@hbu.cn
bKey Laboratory of Medicinal Chemistry and Molecular Diagnosis (Hebei University), Ministry of Education, Key Laboratory of Chemical Biology of Hebei Province, Hebei University, Baoding, P. R. China
cDepartment of Immunology, School of Basic Medical Science, Hebei University, Baoding 071002, P. R. China
First published on 15th November 2021
Abstract
Correction for ‘Synthesis, self-aggregation and cryopreservation effects of perylene bisimide–glycopeptide conjugates’ by Xu He et al., Chem. Commun., 2021, DOI: 10.1039/d1cc03835d.
The authors regret that there was an error in the enhanced cell viabilities of PBI-AFF-Glu and PBI-AFF-Gal given on page 3. The sentence should read:
“The enhanced cell viabilities of PBI-AFF-Glu were 12.90 ± 0.36% (A549, 0.5 mg) and 19.43 ± 1.90% (A549, 1.0 mg) and 9.40 ± 0.81% (GES-1, 0.5 mg) and 16.63 ± 1.76% (GES-1, 1.0 mg). On the other hand, the enhanced cell viabilities of PBI-AFF-Gal were 7.73 ± 4.35% (A549, 0.5 mg) and 15.03 ± 1.40% (A549, 1.0 mg) and 3.96 ± 3.43% (GES-1, 0.5 mg) and 9.93 ± 1.22% (GES-1, 1.0 mg).”
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2021 |